Literature DB >> 32439203

Pathogenic variants in COL6A3 cause Ullrich-like congenital muscular dystrophy in young Labrador Retriever dogs.

Véronique Bolduc1, Katie M Minor2, Ying Hu1, Rupleen Kaur1, Steven G Friedenberg3, Samantha Van Buren2, Ling T Guo4, Joseph C Glennon5, Katia Marioni-Henry6, James R Mickelson2, Carsten G Bönnemann7, G Diane Shelton8.   

Abstract

The collagen VI-related muscular dystrophies in people include a broad spectrum of diseases ranging from the severe Ullrich congenital muscular dystrophy to the mild Bethlem myopathy. Clinical features are attributable to both muscle and connective tissue and include progressive muscle weakness and respiratory failure, hyperlaxity of distal joints, and progressive contracture of large joints. Here we describe two different COL6A3 pathogenic variants in Labrador Retriever dogs that result in autosomal recessive or autosomal dominant congenital myopathies with hyperlaxity of distal joints and joint contracture, similar to the condition in people.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine; Collagen VI; Muscle; Myopathy

Mesh:

Substances:

Year:  2020        PMID: 32439203      PMCID: PMC7292757          DOI: 10.1016/j.nmd.2020.03.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  24 in total

1.  MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.

Authors:  Alan H Beggs; Johann Böhm; Elizabeth Snead; Marek Kozlowski; Marie Maurer; Katie Minor; Martin K Childers; Susan M Taylor; Christophe Hitte; James R Mickelson; Ling T Guo; Andrew P Mizisin; Anna Buj-Bello; Laurent Tiret; Jocelyn Laporte; G Diane Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-03       Impact factor: 11.205

2.  Muscular dystrophy in a family of Labrador Retrievers with no muscle dystrophin and a mild phenotype.

Authors:  Natassia M Vieira; Ling T Guo; Elicia Estrela; Louis M Kunkel; Mayana Zatz; G Diane Shelton
Journal:  Neuromuscul Disord       Date:  2015-03-03       Impact factor: 4.296

3.  Expression of the collagen VI α5 and α6 chains in normal human skin and in skin of patients with collagen VI-related myopathies.

Authors:  Patrizia Sabatelli; Sudheer K Gara; Paolo Grumati; Anna Urciuolo; Francesca Gualandi; Rosa Curci; Stefano Squarzoni; Alessandra Zamparelli; Elena Martoni; Luciano Merlini; Mats Paulsson; Paolo Bonaldo; Raimund Wagener
Journal:  J Invest Dermatol       Date:  2010-09-30       Impact factor: 8.551

Review 4.  The collagen VI-related myopathies: muscle meets its matrix.

Authors:  Carsten G Bönnemann
Journal:  Nat Rev Neurol       Date:  2011-06-21       Impact factor: 42.937

5.  Sarcoglycan isoforms in skeletal muscle.

Authors:  L A Liu; E Engvall
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

6.  Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development.

Authors:  I Leivo; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.

Authors:  William McLaren; Bethan Pritchard; Daniel Rios; Yuan Chen; Paul Flicek; Fiona Cunningham
Journal:  Bioinformatics       Date:  2010-06-18       Impact factor: 6.937

8.  Centronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide.

Authors:  Marie Maurer; Jérôme Mary; Laurent Guillaud; Marilyn Fender; Manuel Pelé; Thomas Bilzer; Natasha Olby; Jacques Penderis; G Diane Shelton; Jean-Jacques Panthier; Jean-Laurent Thibaud; Inès Barthélémy; Geneviève Aubin-Houzelstein; Stéphane Blot; Christophe Hitte; Laurent Tiret
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

9.  A COLQ missense mutation in Labrador Retrievers having congenital myasthenic syndrome.

Authors:  Caitlin J Rinz; Jonathan Levine; Katie M Minor; Hammon D Humphries; Renee Lara; Alison N Starr-Moss; Ling T Guo; D Colette Williams; G Diane Shelton; Leigh Anne Clark
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

10.  Sarcolemmal specific collagen VI deficient myopathy in a Labrador Retriever.

Authors:  K Marioni-Henry; P Haworth; H Scott; P Witte; L T Guo; G Diane Shelton
Journal:  J Vet Intern Med       Date:  2013-10-21       Impact factor: 3.333

View more
  5 in total

1.  Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation.

Authors:  G Diane Shelton; Katie M Minor; Ling T Guo; Steven G Friedenberg; Jonah N Cullen; Jeffrey M Hord; David Venzke; Mary E Anderson; Megan Devereaux; Sally J Prouty; Caryl Handelman; Kevin P Campbell; James R Mickelson
Journal:  Neuromuscul Disord       Date:  2021-07-28       Impact factor: 4.296

Review 2.  Dog-human translational genomics: state of the art and genomic resources.

Authors:  Stefano Pallotti; Ignazio S Piras; Andrea Marchegiani; Matteo Cerquetella; Valerio Napolioni
Journal:  J Appl Genet       Date:  2022-09-08       Impact factor: 2.653

3.  Congenital muscular dystrophy in a dog with a LAMA2 gene deletion.

Authors:  G Diane Shelton; Katie M Minor; Stephanie Thomovsky; Ling T Guo; Steven G Friedenberg; Jonah N Cullen; James R Mickelson
Journal:  J Vet Intern Med       Date:  2021-12-02       Impact factor: 3.333

4.  LAMA2 Nonsense Variant in an Italian Greyhound with Congenital Muscular Dystrophy.

Authors:  Matthias Christen; Victoria Indzhova; Ling T Guo; Vidhya Jagannathan; Tosso Leeb; G Diane Shelton; Josep Brocal
Journal:  Genes (Basel)       Date:  2021-11-19       Impact factor: 4.096

5.  Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.

Authors:  Katharina Klose; Eva-Maria Packeiser; Petra Müller; José Luis Granados-Soler; Jan Torben Schille; Sandra Goericke-Pesch; Manfred Kietzmann; Hugo Murua Escobar; Ingo Nolte
Journal:  PLoS One       Date:  2021-09-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.